Novidades sobre o produto

GEA introduces pharma separator lines aseptic and pure for biopharmaceutical separation processes

22 Aug 2022

With a view to the very different hygiene requirements in individual pharmaceutical processes, GEA engineers developed a new, fully comprehensive portfolio of plug & produce pharmaceutical separators. GEA presents the separator lines aseptic and pure at ACHEMA 2022 in Frankfurt. The aseptic and pure separator lines are used in all pharmaceutical and biotechnological downstream processes and meet customer-specific as well as process-required demands. GEA sees the uncompromising hygienic design reliability and the possibility of maximum yield in the respective processes as the decisive plus points of aseptic and pure.

The pharmaceutical separator lines "aseptic" and "pure" are developed to the highest GEA standards at the German GEA Westfalia Separator plant in Oelde, where they are built and tested. All features for pharmaceutical cleanliness requirements such as an automatic CIP (Cleaning-in-Place), SIP (-Sterilization-in-Place), easy validation and a high-end qualification package are included. In addition, the pharmaceutical separators support GEA customers in their quality standard reviews with the help of the cGMP validation process ("Current Good Manufacturing Practice, cGMP).

GEA separator line aseptic

The aseptic line includes SIP processing and stands for the highest hygienic pharmaceutical requirements. It offers customers with highly hygienic processes gentle processing of, for example, human and veterinary vaccines, monoclonal antibodies (mAb), e-coli, insulin, starter cultures and probiotic products.

GEA's separator line aseptic including SIP offers customers with highly hygienic processes gentle processing of, for example, human and veterinary vaccines, monoclonal antibodies (mAb), e-coli, insulin, starter cultures and probiotic products. (Photo: GEA)

GEA's separator line aseptic including SIP offers customers with highly hygienic processes gentle processing of, for example, human and veterinary vaccines, monoclonal antibodies (mAb), e-coli, insulin, starter cultures and probiotic products. (Photo: GEA)

GEA separator line pure

The pure line gives highest variability and is perfectly tailored to the diverse process requirements of the biopharma industry. It is recommended for customers with applications with varying hygienic requirements, such as for food supplements, therapeutic proteins, pharmaceutical extractions, and in the recovery of extracellular and intracellular enzymes. Here, the separator line pure offers the highest variability in the selection of required hygienic components.

GEA presents the separator pure line at ACHEMA 2022. (Photo: GEA)

GEA presents the separator pure line at ACHEMA 2022. (Photo: GEA)

flexChange 3-in-1 bowl concept from GEA for producers with frequent product changes

The GEA flexChange 3-in-1 bowl concept of the new separator series aseptic and pure ensures high flexibility, which means a plus in competitiveness especially for Contract Manufacturing Organizations (CMO) and operators of pilot plants. The principle: the customer selects the bowl variant ideally suited to his products with solid content from 5 vol% to 35 vol% or higher, depending on product. This results in maximum yield with every product change. One GEA Pharma Skid with flexChange concept thus replaces three plants.

www.gea.com/energizing-pharma

Contact

Dr. Michael Golek

Phone: 49 211 9136 1505

Media Relations

GEA Group Aktiengesellschaft

Peter-Müller-Str. 12


40468

Düsseldorf


Germany

+49 211 9136-0

About GEA

A GEA é uma das maiores fornecedoras para a indústria de processamento de alimentos e para uma ampla variedade de outras indústrias que geraram receitas consolidadas de aproximadamente EUR 4,9 bilhões em 2019.

O grupo internacional de tecnologia é especializado em maquinaria e plantas, além de tecnologia e componentes para processamentos. A GEA fornece soluções de energia sustentável para processos de produção sofisticados em diversos mercados de usuários finais e oferece um portfólio abrangente de serviços. O grupo gera cerca de 70% da sua receita no setor de alimentos e bebidas, que desfruta de um crescimento sustentável a longo prazo. Desde 31 de dezembro de 2018, a empresa empregou mais de 18.500 pessoas em todo o mundo. A GEA é líder de mercado e tecnologia em suas áreas de negócios. A empresa está listada na bolsa alemã MDAX (G1A, WKN 660 200), no Índice STOXX® Europe 600 e nos Índices selecionados de Sustentabilidade Global MSCI. Maiores informações disponíveis na Internet em gea.com. Se você não quiser mais receber informações da GEA, por favor envie um e-mail para pr@gea.com.
Receba notícias da GEA

Mantenha-se atualizado com as inovações e histórias da GEA, se registrando para receber notícias sobre a GEA.

Entre em contato

Estamos aqui para ajudar! Com apenas poucos detalhes poderemos responder à sua pergunta.